EU Health Product Manufacturers Call for Guidance on Flexibility of Claims Wording

09 Feb 2012 --- Welcoming the European Commission’s decision to allow the food sector some flexibility when making claims, EHPM said that because of concerns that the average consumer will not understand some of the scientific terminology, claims should be accompanied by further explanatory details.

Feb 9 2012 --- Guidance on the acceptability of flexible wordings when communicating article 13.1 health claims to consumers will be valuable for both enforcement bodies and companies, the European Federation of Associations of Health Product Manufacturers (EHPM) has said.

Welcoming the European Commission’s decision to allow the food sector some flexibility when making claims, EHPM said that because of concerns that the average consumer will not understand some of the scientific terminology, claims should be accompanied by further explanatory details.

“We have concerns whether the average consumer will understand scientific terminology such as ‘Homocystein metabolism’, ‘normal neurotransmission’, ‘cell division and differentiation’ and ‘sulphur amino acid metabolism’,” said EHPM Chairman Peter van Doorn. “Consumers may not interpret correctly many of the wordings listed in the annex of the draft Regulation establishing a list of permitted health claims. Therefore, it is essential that wordings can be adapted to consumer language.”

The European trade association highlighted the dual and equal requirement in the Regulation for claims to be “based on generally accepted scientific evidence” and “well understood by the average consumer”.

EHPM said that based on these requirements companies should be permitted to mention some of the specific functions and definitions cited in the European Food Safety Authority’s (EFSA) opinions, stating that this would provide consumers with valuable advice.
 
“We believe that such clarifications would greatly assist consumer understanding,” said van Doorn. “For example, a message such as ‘Pantothenic acid contributes to normal mental performance’, which relates to EFSA’s definition of mental performance as standing for those aspects of brain and nerve functions which determine aspects like concentration, learning, memory and reasoning. We hope that the European Commission and Member States take into consideration this approach with regard to flexibility.”

Related Articles

Health & Nutrition News

Sensus Expands Regulatory Team, Eyes Prebiotic Claims Research

17 Oct 2014 --- As from October 2014, senior scientist Elaine Vaughan will join the Scientific and Regulatory Affairs department of Sensus building on previous pioneering research on inulin applied to human health.

Regulatory News

GanedenBC30 Probiotic Approved in Japan, Taiwan, India & Philippines

07 Oct 2014 --- Ganeden Biotech, a recognized world leader in the manufacturing and marketing of probiotics, revealed today that GanedenBC30 (Bacillus coagulans GBI-30, 6086) has been approved by food and drug authorities in four significant Asian markets; this means that GanedenBC30’s digestive and immune benefits are now available to Japan, India, Taiwan and the Philippines as an ingredient for food and beverage fortification.

Food Ingredients News

Glanbia Nutritionals Develops Gluten-Free Oats With High Traceability and Purity

03 Oct 2014 --- Ingredient innovator Glanbia Nutritionals announces a major breakthrough in gluten-free purity with the launch of OatPure gluten-free oats. Certified at max 10 parts per million (ppm) gluten to exceed industry standards, OatPure oats are developed at Glanbia’s new state-of-the-art food grade milling facility in Portlaoise, Ireland, guaranteeing gluten-free oat traceability and purity.

Regulatory News

Novel Foods Workshop to Address Regulation Developments

03 Oct 2014 --- The cornerstone of EU Food Law is the general principle that food and food ingredients shall not be placed on the market if it is unsafe. Prof. Hans Verhagen is Senior Scientific Advisor “Nutrition and Food Safety” at RIVM Netherlands and a board-certified toxicologist. He is a member of the EFSA-NDA panel and chairs the Novel Foods working group.

More Articles
URL : http://www.nutritioninsight.com:80/news/EU-Health-Product-Manufacturers-Call-for-Guidance-on-Flexibility-of-Claims-Wording.html